Healthcare of Today Acquires Macuclear

Healthcare of Today, Inc. today announces that it has completed the acquisition of MacuCLEAR, Inc., a specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye.

MacuCLEAR’s ( groundbreaking work leverages its unique understanding of ocular pharmacology and drug development to advance a pipeline of proprietary pharmaceuticals. MC-1101, MacuCLEAR’s primary product compound, is a patented, preservative-free drug delivered with a proprietary delivery system for treating and stopping the progression of dry Age-related Macular Degeneration (AMD). MacuCLEAR has an active IND for MC-1101 and has completed a successful Phase Ib/Proof of Concept human clinical trial.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: